Insiders · Profile

Reich Kristian

Chief Scientific Officer at MoonLake Immunotherapeutics. Filing since 14 Feb 2024. CIK 0001920553

Company
Date
Role
Action
Shares
Amount
Of holding
27 Jul 2026
Chief Scientific Officer
Sold on a plan
1,100
$22.00K
0.0%
22 Jul 2026
Chief Scientific Officer
Sold on a plan
2,448
$48.96K
0.1%
21 Jul 2026
Chief Scientific Officer
Sold on a plan
50,000
$1.00M
1.8%
20 Jul 2026
Chief Scientific Officer
Sold on a plan
43,700
$877.93K
1.6%
15 Jul 2026
Chief Scientific Officer
Sold on a plan
16,105
$322.26K
0.6%
17 Jun 2026
Chief Scientific Officer
Sold on a plan
50,000
$971.50K
1.7%
16 Jun 2026
Chief Scientific Officer
Sold on a plan
50,000
$935.00K
1.7%
15 Jun 2026
Chief Scientific Officer
Sold on a plan
50,000
$944.50K
1.7%
9 Dec 2025
Chief Scientific Officer
Sold at will
72,908
$1.05M
100%
8 Dec 2025
Chief Scientific Officer
Sold at will
130,000
$1.96M
64.1%
28 Feb 2024
Chief Scientific Officer
Sold on a plan
31,910
$1.76M
1.1%
28 Feb 2024
Chief Scientific Officer
Sold on a plan
28,090
$1.54M
40.1%
27 Feb 2024
Chief Scientific Officer
Sold on a plan
29,491
$1.62M
1.0%
27 Feb 2024
Chief Scientific Officer
Sold on a plan
29,431
$1.62M
29.6%
21 Feb 2024
Chief Scientific Officer
Sold on a plan
569
$31.47K
0.6%
21 Feb 2024
Chief Scientific Officer
Sold on a plan
509
$28.15K
0.0%
20 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$574.50K
0.3%
20 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$574.30K
9.1%
16 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$601.50K
8.3%
16 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$601.50K
0.3%
15 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$601.70K
0.3%
15 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$601.60K
7.7%
14 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$624.30K
7.1%
14 Feb 2024
Chief Scientific Officer
Sold on a plan
10,000
$624.20K
0.3%
24 decisions on file.